Screening for prostate cancer

Published in NPS Direct

Date published: About this date

Clinical content may change after this date. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment.

Screening for prostate cancer

Prostate cancer is the most common malignancy in Australian men. Does measuring the concentration of prostate specific antigen (PSA) in the blood help in the assessment and management of early prostate cancer? RACGP guidelines recommend against routine PSA screening unless the man specifically asks for it and is fully counselled on the pros and cons. Without understanding the underlying biology or without applying refinements measuring prostate specific antigen may result in more harm than good.

Read more about PSA